Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo

Cancer Genetics and Cytogenetics

Volumn 184, Issue 2, 2008, Pages 113-118

  Ohsaka, Akimichi ^a   Otsubo, Kaori ^d   Yokota, Harushige ^b   Hisa, Tomoko ^b   Saito, Hajime ^c   Kozaki, Takazumi ^d  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hitachi   (Japan)

^c MITO SAISEIKAI GENERAL HOSPITAL   (Japan)

^d SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; CHROMOSOME 12; CHROMOSOME 12Q; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME BANDING PATTERN; CHROMOSOME INVERSION; CHROMOSOME INVERSION 16; CHROMOSOME TRANSLOCATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; HUMAN; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTRAL KARYOTYPING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INVERSION, CHROMOSOME; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SPECTRAL KARYOTYPING; TRANSLOCATION, GENETIC;

EID: 46249120426     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.04.008     Document Type: Article

References (24)

1. Le Beau M., Larson R., and Bitter M. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. N Engl J Med 309 (1983) 630-636
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., and Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med 103 (1985) 626-629
3. Liu P.P., Hajra A., Wijmenga C., and Collins F.S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 85 (1995) 2289-2302
4. Langabeer S.E., Walker H., Gale R.E., Wheatley K., Burnett A.K., Goldstone A.H., and Linch D.C. Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. Br J Haematol 96 (1997) 736-739
5. Shigesada K., van de Sluis B., and Liu P.P. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11. Oncogene 23 (2004) 4297-4307
6. Reilly J.T. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?. Br J Haematol 128 (2005) 18-34
7. Castilla L.H., Garrett L., and Adya N. The fusion gene CBFB-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet 23 (1999) 144-146
8. Berger R., Derre J., le Coniat M., Hebert J., Romana P.S., and Jonveaux P. Inversion-associated translocations in acute myelomonocytic leukemia with eosinophilia. Genes Chromosomes Cancer 12 (1995) 58-62
9. Dierlamm J., Stul M., Vranckx H., Michaux L., olde Weghuis D.E.M., Speleman F., Selleslag D., Kramer M.H.H., Noens L.A., Cassiman J.-J., van den Berghe H., and Hagemeijer A. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia. Genes Chromosomes Cancer 22 (1998) 87-94
10. Martinez-Climent J.A., Comes A.M., Vizcarra E., Reshmi S., Benet I., Marugan I., Tormo M., Terol M.J., Solano C., Arbona C., Prosper F., Barragan E., Bolufer P., Rowley J.D., and Garcia-Conde J. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridizaition analysis. Cancer Genet Cytogenet 110 (1999) 111-114
11. Maarek O., Salabelle A., Le Coniat M.B., Daniel M.T., and Berger R. Chromosome 16 inversion-associated translocation: two new cases. Cancer Genet Cytogenet 114 (1999) 126-129
12. Reddy K.S., Wang S., Montgomery P., Grove W., and Robertson L.E. Fluorescence in situ hybridization identifies inversion 16 masked by t(10;16)(q24;q22), t(7;16) (q21;q22), and t(2;16)(q37;q22) in three cases of AML-M4Eo. Cancer Genet Cytogenet 116 (2000) 148-152
13. Li S., Couzi R.J., Thomas G.H., Friedman A.D., and Borowitz M.J. A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy. Cancer Genet Cytogenet 125 (2001) 74-77
14. Aventín A., Espadaler M., Casas S., Duarte J., Nomdedéu J., and Sierra J. Chromosome 16 inversion-associated translocations in acute myeloid leukemia elucidated using a dual-color CBFB DNA probe. Cancer Genet Cytogenet 134 (2002) 142-144
15. Ohsaka A., Hisa T., Watanabe N., Kojima H., and Nagasawa T. Tetrasomy 21 as a sole chromosome abnormality in acute myeloid leukemia: fluorescence in situ hybridization and spectral karyotyping analyses. Cancer Genet Cytogenet 134 (2002) 60-64
16. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., and Ried T. Multicolor spectral karyotyping of human chromosomes. Science 273 (1996) 494-497
17. Ohsaka A., Hoshino S., Kobayashi M., Kudo H., and Kawaguchi R. Blast crisis of Philadelphia chromosome-positive chronic myeloid leukaemia carrying micro-bcr breakpoint (e19a2 and e191a). Br J Haematol 118 (2002) 251-254
18. Pedersen-Bjergaard J., Andersen M.K., Christiansen D.H., and Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99 (2002) 1909-1912
19. Dissing M., Le Beau M.M., and Pedersen-Bjergaard J. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?. J Clin Oncol 16 (1998) 1890-1896
20. Schnittger S., Bacher U., Haferlach C., Kern W., and Haferlach T. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients. Leukemia 21 (2007) 725-731
21. Andersen M.K., Larson R.A., Mauritzson N., Schnittger S., Jhanwar S.C., and Pedersen-Bjergaard J. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33 (2002) 395-400
22. Chaffanet M., Mozziconacci M.J., Fernandez F., Sainty D., Lafage-Pochitaloff M., Birnbaum D., and Pébusque M.J. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16). Genes Chromosomes Cancer 26 (1999) 161-165
23. Loh M.L., Vattikuti S., Schubbert S., Reynolds M.G., Carlson E., Lieuw K.H., Cheng J.W., Lee C.M., Stokoe D., Bonifas J.M., Curtiss N.P., Gotlib J., Meshinchi S., Le Beau M.M., Emanuel P.D., and Shannon K.M. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103 (2004) 2325-2331
24. Christiansen D.H., Desta F., Andersen M.K., and Pedersen-Bjergaard J. Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations. Genes Chromosomes Cancer 46 (2007) 517-521